Rhyannon Spangler
AbbVie (United States)(US)
Publications by Year
Research Areas
Microbial metabolism and enzyme function, Peptidase Inhibition and Analysis, Nitric Oxide and Endothelin Effects, Protein Kinase Regulation and GTPase Signaling, Obstructive Sleep Apnea Research
Most-Cited Works
- → Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment(2010)843 cited
- → Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer(2015)191 cited
- → NFATc3 Mediates Chronic Hypoxia-induced Pulmonary Arterial Remodeling with α-Actin Up-regulation(2007)106 cited
- → Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours(2013)90 cited
- → The Role of LOX and LOXL2 in the Pathogenesis of an Experimental Model of Choroidal Neovascularization(2015)34 cited
- → Intermittent hypoxia/hypercapnia (IH) activates NFAT (nuclear factor of activated T‐cells) in the cardiovascular system of mice(2007)
- → Abstract C042: TOP1i-ADC demonstrates immune-stimulating activity in colorectal cancer explants(2026)
- → NFAT plays a role in chronic hypoxia‐induced pulmonary arterial hypertension(2006)
- → NFATc3 mediates Chronic Hypoxia (CH)‐induced soluble guanylyl cyclase‐α (sGC‐α) up‐regulation in the lung(2007)